Southern Brian D
Departments of Pulmonary Medicine and Inflammation and Immunity, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
Cleve Clin J Med. 2020 Jun 18. doi: 10.3949/ccjm.87a.ccc026.
Analyses of COVID-19 patients with preexisting interstitial lung disease (ILD) or pulmonary sarcoidosis is lacking but registries are ongoing. Treatment of COVID-19 in patients with underlying ILD or sarcoidosis may include hospital admission, possible drug treatment, caution with steroids, and avoidance of mechanical ventilation in acute exacerbation of ILD. Patients with COVID-19 respiratory illness are at risk for developing ILD.
目前缺乏对已有间质性肺疾病（ILD）或肺结节病的新冠肺炎患者的分析，但相关登记工作正在进行。对于患有基础ILD或结节病的新冠肺炎患者，治疗可能包括住院、可能的药物治疗、谨慎使用类固醇，以及在ILD急性加重时避免机械通气。新冠肺炎呼吸道疾病患者有发生ILD的风险。
